These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24632412)

  • 1. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
    Aune SE; Herr DJ; Mani SK; Menick DR
    J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
    Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
    Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
    J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.
    Herr DJ; Baarine M; Aune SE; Li X; Ball LE; Lemasters JJ; Beeson CC; Chou JC; Menick DR
    J Mol Cell Cardiol; 2018 Jan; 114():309-319. PubMed ID: 29224834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
    Concors SJ; Hernandez PT; O'Brien C; DePaolo J; Murken DR; Aufhauser DD; Wang Z; Xiong Y; Krumeich L; Ge G; Beier UH; Bhatti TR; Kozikowski AP; Avelar LAA; Kurz T; Hancock WW; Levine MH
    Transplantation; 2024 Oct; 108(10):2084-2092. PubMed ID: 38685198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.
    Zhang LX; Zhao Y; Cheng G; Guo TL; Chin YE; Liu PY; Zhao TC
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2154-63. PubMed ID: 20382965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway.
    Guo Y; Li Z; Shi C; Li J; Yao M; Chen X
    Int J Mol Med; 2017 Oct; 40(4):999-1008. PubMed ID: 28849190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
    Koppel I; Timmusk T
    Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Baumgardt SL; Fang J; Fu X; Liu Y; Xia Z; Zhao M; Chen L; Mishra R; Gunasekaran M; Saha P; Forbess JM; Bosnjak ZJ; Camara AKS; Kersten JR; Thorp EB; Kaushal S; Ge ZD
    Cardiovasc Res; 2024 Oct; 120(12):1456-1471. PubMed ID: 39001869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
    Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
    BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
    Zhao TC; Cheng G; Zhang LX; Tseng YT; Padbury JF
    Cardiovasc Res; 2007 Dec; 76(3):473-81. PubMed ID: 17884027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
    Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
    Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II histone deacetylases require P/Q-type Ca
    Urbano FJ; Bisagno V; Mahaffey S; Lee SH; Garcia-Rill E
    Sci Rep; 2018 Sep; 8(1):13156. PubMed ID: 30177751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtinol abrogates late phase of cardiac ischemia preconditioning in rats.
    Safari F; Shekarforoosh S; Hashemi T; Namvar Aghdash S; Fekri A; Safari F
    J Physiol Sci; 2017 Jul; 67(4):515-522. PubMed ID: 27677982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway.
    Wu Y; Leng Y; Meng Q; Xue R; Zhao B; Zhan L; Xia Z
    J Diabetes Res; 2017; 2017():8208065. PubMed ID: 28191472
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.
    Li Y; Zhao T; Liu B; Halaweish I; Mazitschek R; Duan X; Alam HB
    J Trauma Acute Care Surg; 2015 Feb; 78(2):378-85. PubMed ID: 25757125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid-electrolyte homeostasis requires histone deacetylase function.
    Hyndman KA; Speed JS; Mendoza LD; Allan JM; Colson J; Sedaka R; Jin C; Jung HJ; El-Dahr S; Pollock DM; Pollock JS
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32673289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway.
    Wang K; Tang R; Wang S; Xiong Y; Wang W; Chen G; Zhang K; Li P; Tang YD
    J Cardiovasc Pharmacol; 2022 Feb; 79(2):217-228. PubMed ID: 34983914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities.
    Lkhagva B; Kao YH; Lee TI; Lee TW; Cheng WL; Chen YJ
    Epigenetics; 2018; 13(4):376-385. PubMed ID: 29613828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.